Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Access to essential medicines in 195 countries: A human rights approach to sustainable development.

Perehudoff SK, Alexandrov NV, Hogerzeil HV.

Glob Public Health. 2018 Sep 6:1-14. doi: 10.1080/17441692.2018.1515237. [Epub ahead of print]

PMID:
30187828
2.

Medicine procurement and the use of flexibilities in the Agreement on Trade-Related Aspects of Intellectual Property Rights, 2001-2016.

't Hoen EF, Veraldi J, Toebes B, Hogerzeil HV.

Bull World Health Organ. 2018 Mar 1;96(3):185-193. doi: 10.2471/BLT.17.199364. Epub 2018 Feb 5.

3.

Policy approaches to improve availability and affordability of medicines in Mexico - an example of a middle income country.

Moye-Holz D, van Dijk JP, Reijneveld SA, Hogerzeil HV.

Global Health. 2017 Aug 1;13(1):53. doi: 10.1186/s12992-017-0281-1.

4.

Essential medicines for universal health coverage - Authors' reply.

Wirtz VJ, Hogerzeil HV, Gray AL; Lancet Commission on Essential Medicines Policies.

Lancet. 2017 May 13;389(10082):1881-1882. doi: 10.1016/S0140-6736(17)31209-6. Epub 2017 May 11. No abstract available.

PMID:
28513447
5.

Essential medicines for universal health coverage.

Wirtz VJ, Hogerzeil HV, Gray AL, Bigdeli M, de Joncheere CP, Ewen MA, Gyansa-Lutterodt M, Jing S, Luiza VL, Mbindyo RM, Möller H, Moucheraud C, Pécoul B, Rägo L, Rashidian A, Ross-Degnan D, Stephens PN, Teerawattananon Y, 't Hoen EF, Wagner AK, Yadav P, Reich MR.

Lancet. 2017 Jan 28;389(10067):403-476. doi: 10.1016/S0140-6736(16)31599-9. Epub 2016 Nov 8. Review. No abstract available.

PMID:
27832874
6.

Essential medicines are still essential.

Gray AL, Wirtz VJ, 't Hoen EF, Reich MR, Hogerzeil HV.

Lancet. 2015 Oct 24;386(10004):1601-3. doi: 10.1016/S0140-6736(15)00514-0. No abstract available.

PMID:
26595616
7.

Impacts of a new insurance benefit with capitated provider payment on healthcare utilization, expenditure and quality of medication prescribing in China.

Sun J, Zhang X, Zhang Z, Wagner AK, Ross-Degnan D, Hogerzeil HV.

Trop Med Int Health. 2016 Feb;21(2):263-74. doi: 10.1111/tmi.12636. Epub 2015 Dec 1.

8.

Achieving universal health coverage-the case of Zhuhai city.

Sun J, Zhang XT, Zhang Z, Hogerzeil HV.

J Evid Based Med. 2014 Aug;7(3):154-62. doi: 10.1111/jebm.12110.

PMID:
25156496
9.

Health-sector reform in China and access to essential medicines.

Hogerzeil HV, Jing S.

Lancet Glob Health. 2013 Oct;1(4):e174-5. doi: 10.1016/S2214-109X(13)70077-9. Epub 2013 Sep 24. No abstract available.

10.

Is the pharmaceutical industry improving with regard to access to essential medicines?

Hogerzeil HV, Iyer JK, Urlings L, Prasad T, Brewer S.

Lancet Glob Health. 2014 Mar;2(3):e139-40. doi: 10.1016/S2214-109X(13)70159-1. Epub 2014 Jan 31. No abstract available.

11.

A quiet revolution in global public health: The World Health Organization's Prequalification of Medicines Programme.

't Hoen EF, Hogerzeil HV, Quick JD, Sillo HB.

J Public Health Policy. 2014 May;35(2):137-61. doi: 10.1057/jphp.2013.53. Epub 2014 Jan 16.

PMID:
24430804
12.

Big Pharma and social responsibility--the Access to Medicine Index.

Hogerzeil HV.

N Engl J Med. 2013 Sep 5;369(10):896-9. doi: 10.1056/NEJMp1303723. No abstract available.

PMID:
24004116
13.

Promotion of access to essential medicines for non-communicable diseases: practical implications of the UN political declaration.

Hogerzeil HV, Liberman J, Wirtz VJ, Kishore SP, Selvaraj S, Kiddell-Monroe R, Mwangi-Powell FN, von Schoen-Angerer T; Lancet NCD Action Group.

Lancet. 2013 Feb 23;381(9867):680-9. doi: 10.1016/S0140-6736(12)62128-X. Epub 2013 Feb 12. Review.

PMID:
23410612
14.

Global aspects of drug development.

Hoppu K, Hogerzeil HV.

Handb Exp Pharmacol. 2011;205:353-72. doi: 10.1007/978-3-642-20195-0_18.

PMID:
21882121
15.

Access to essential medicines in national constitutions.

Perehudoff SK, Laing RO, Hogerzeil HV.

Bull World Health Organ. 2010 Nov 1;88(11):800. doi: 10.2471/BLT.10.078733. No abstract available.

16.

Should medical students learn to develop a personal formulary? An international, multicentre, randomised controlled study.

De Vries TP, Daniels JM, Mulder CW, Groot OA, Wewerinke L, Barnes KI, Bakathir HA, Hassan NA, Van Bortel L, Kriska M, Santoso B, Sanz EJ, Thomas M, Ziganshina LE, Bezemer PD, Van Kan C, Richir MC, Hogerzeil HV.

Eur J Clin Pharmacol. 2008 Jun;64(6):641-6. doi: 10.1007/s00228-008-0465-y.

17.

Boosting access to essential medicines for children.

Hogerzeil HV, Hill S, Rago L.

Lancet. 2006 Oct 21;368(9545):1419. No abstract available.

PMID:
17055942
18.

Is access to essential medicines as part of the fulfilment of the right to health enforceable through the courts?

Hogerzeil HV, Samson M, Casanovas JV, Rahmani-Ocora L.

Lancet. 2006 Jul 22;368(9532):305-11.

PMID:
16860700
19.

Essential medicines and human rights: what can they learn from each other?

Hogerzeil HV.

Bull World Health Organ. 2006 May;84(5):371-5. Epub 2006 May 17.

20.

The concept of essential medicines: lessons for rich countries.

Hogerzeil HV.

BMJ. 2004 Nov 13;329(7475):1169-72. Review. No abstract available.

21.

Could the WHO model list of essential medicines do more for the safe and appropriate use of injections?

Logez SM, Hutin YJ, Holloway K, Gray R, Hogerzeil HV.

J Clin Pharmacol. 2004 Oct;44(10):1106-13. Review.

PMID:
15342611
22.

Ensuring ethical drug promotion--whose responsibility?

Quick JD, Hogerzeil HV, Rägo L, Reggi V, de Joncheere K.

Lancet. 2003 Aug 30;362(9385):747. No abstract available.

PMID:
12957107
23.

Opposing the motion.

Hogerzeil HV.

Trans R Soc Trop Med Hyg. 2003 Jan-Feb;97(1):14-5. No abstract available.

PMID:
12886796
24.

Ten best readings in ... essential medicines.

Quick JD, Hogerzeil HV.

Health Policy Plan. 2003 Mar;18(1):119-21. No abstract available.

PMID:
12582115
25.

Twenty-five years of essential medicines.

Quick JD, Hogerzeil HV, Velasquez G, Rago L.

Bull World Health Organ. 2002;80(11):913-4. No abstract available.

26.

Prescription habits of dispensing and non-dispensing doctors in Zimbabwe.

Trap B, Hansen EH, Hogerzeil HV.

Health Policy Plan. 2002 Sep;17(3):288-95.

PMID:
12135995
27.

Can hysterosalpingocontrast-sonography replace hysterosalpingography in the assessment of tubal subfertility?

Dijkman AB, Mol BW, van der Veen F, Bossuyt PM, Hogerzeil HV.

Eur J Radiol. 2000 Jul;35(1):44-8.

PMID:
10930765
28.

[Pregnancy course and outcome in 2956 pregnancies after in-vitro fertilization in Netherlands].

Koudstaal J, Van Dop PA, Hogerzeil HV, Kremer JA, Naaktgeboren N, Van Os HC, Tiemessen CH, Visser GH.

Ned Tijdschr Geneeskd. 1999 Nov 20;143(47):2375-80. Dutch.

PMID:
10590776
29.

Intervention research in rational use of drugs: a review.

le Grand A, Hogerzeil HV, Haaijer-Ruskamp FM.

Health Policy Plan. 1999 Jun;14(2):89-102. Review.

PMID:
10538724
30.

The quality and stability of essential drugs in rural Zimbabwe: controlled longitudinal study.

Nazerali H, Hogerzeil HV.

BMJ. 1998 Aug 22;317(7157):512-3. No abstract available.

31.

Diagnosis of ectopic pregnancy after in vitro fertilization and embryo transfer.

Mol BW, van der Veen F, Hajenius PJ, Engelsbel S, Ankum WM, Hogerzeil HV, Hemrika DJ, Bossuyt PM.

Fertil Steril. 1997 Dec;68(6):1027-32.

PMID:
9418692
33.

Guidelines for drug donations.

Hogerzeil HV, Couper MR, Gray R.

BMJ. 1997 Mar 8;314(7082):737-40.

34.

Instability of (methyl)ergometrine in tropical climates: an overview.

Hogerzeil HV, Walker GJ.

Eur J Obstet Gynecol Reprod Biol. 1996 Oct;69(1):25-9. Review.

PMID:
8909953
35.
36.

Socio-economic characteristics of artificial insemination donor (AID) couples compared with matched population controls.

Hogerzeil HV, Knijn T, Mol BW.

Eur J Obstet Gynecol Reprod Biol. 1996 Jan;64(1):111-4.

PMID:
8801135
37.

Impact of a short course in pharmacotherapy for undergraduate medical students: an international randomised controlled study.

de Vries TP, Henning RH, Hogerzeil HV, Bapna JS, Bero L, Kafle KK, Mabadeje Af, Santoso B, Smith AJ.

Lancet. 1995 Dec 2;346(8988):1454-7.

PMID:
7490991
38.

Essential drugs for ration kits in developing countries.

Haak H, Hogerzeil HV.

Health Policy Plan. 1995 Mar;10(1):40-9.

PMID:
10172273
39.

Promoting rational prescribing: an international perspective.

Hogerzeil HV.

Br J Clin Pharmacol. 1995 Jan;39(1):1-6. Review.

40.

Substance use in pregnancy: do we care?

Boer K, Smit BJ, van Huis AM, Hogerzeil HV.

Acta Paediatr Suppl. 1994 Nov;404:65-71.

PMID:
7841636
41.

Thyroid function and thyroid size in normal pregnant women living in an iodine replete area.

Berghout A, Endert E, Ross A, Hogerzeil HV, Smits NJ, Wiersinga WM.

Clin Endocrinol (Oxf). 1994 Sep;41(3):375-9.

PMID:
7955445
42.

Treatment of interstitial pregnancy with methotrexate: report of an unsuccessful case.

Voigt RR, van der Veen F, Karsdorp VH, Hogerzeil HV, Ketting BW.

Hum Reprod. 1994 Aug;9(8):1576-9.

PMID:
7989525
43.

The colour of ergometrine injection: how to recognize low level of active ingredient.

Hogerzeil HV, Walker GJ, van de Langerijt AE.

Trop Doct. 1994 Jul;24(3):112-4. No abstract available.

PMID:
8091517
44.

Managing the third stage of labour. Oxytocin more stable in tropical climates.

Hogerzeil HV, Walker GJ, De Goeje MJ.

BMJ. 1994 Jan 1;308(6920):59. No abstract available.

45.

Field tests for rational drug use in twelve developing countries.

Hogerzeil HV, Bimo, Ross-Degnan D, Laing RO, Ofori-Adjei D, Santoso B, Azad Chowdhury AK, Das AM, Kafle KK, Mabadeje AF, et al.

Lancet. 1993 Dec 4;342(8884):1408-10.

PMID:
7901689
46.
47.

Stability of essential drugs during shipment to the tropics.

Hogerzeil HV, Battersby A, Srdanovic V, Stjernstrom NE.

BMJ. 1992 Jan 25;304(6821):210-2.

48.

Stability of essential drugs in Sudan.

Hogerzeil HV, de Goeje MJ, Abu-Reid IO.

Lancet. 1991 Sep 21;338(8769):754-5. No abstract available.

PMID:
1679881
49.

Daily insemination with cryopreserved donor semen is more effective than alternate-day insemination.

Hogerzeil HV, Stevenhagen C, Oosting HJ, Hamerlynck JV.

Int J Fertil. 1991 Sep-Oct;36(5):281-6.

PMID:
1683656
50.

The new emergency health kit.

Hogerzeil HV, Pinel J.

Trop Doct. 1991;21 Suppl 1:47-50. No abstract available.

PMID:
1882431

Supplemental Content

Loading ...
Support Center